SCHEMBL13769671

SCHEMBL13769671

CCOC(=O)Cn1cc(-c2ccccc2Cl)c2c(-c3ccccc3)ncnc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.45
POLB P06746 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
JAK2 O60674 2/20 0.42
JAK3 P52333 2/20 0.42
TP53 P04637 3/20 0.42
MAPT P10636 3/20 0.42
KDM4E B2RXH2 3/20 0.42
ALDH1A1 P00352 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
HPGD P15428 1/20 0.42
GAA P10253 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
PDE4B Q07343 1/20 0.39
PDE4D Q08499 1/20 0.39
P2RX7 Q99572 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13769532 0.88 PDE4B (0.41) SRCNPSR1TP53MAPTKDM4E
SCHEMBL4006132 0.86 P2RX7 (0.43) SRCPOLBMAPTKDM4EALDH1A1
SCHEMBL13769525 0.86 MAPT (0.40) SRCNPSR1TP53MAPTKDM4E
SCHEMBL13769936 0.85 PDE4B (0.42) NPSR1TP53MAPTKDM4EALDH1A1
SCHEMBL13769676 0.85 MAPT (0.39) SRCNPSR1TP53MAPTKDM4E
SCHEMBL13769926 0.83 XDH (0.45) JAK2JAK3TP53MAPTKDM4E
SCHEMBL13769677 0.83 MAPT (0.38) SRCNPSR1JAK2JAK3TP53
SCHEMBL13769538 0.83 MAPT (0.38) SRCNPSR1TP53MAPTKDM4E
SCHEMBL13769386 0.82 MAPT (0.39) SRCNPSR1TP53MAPTKDM4E
SCHEMBL13770142 0.82 JAK2 (0.48) SRCJAK2JAK3TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080682-A1 PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS GLAXO GROUP LIMITED (GB) 2009-07-02 WO disclosed